Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035 [Phase 1]
Phase 1 study to assess the safety, tolerability and pharmacokinetics of ABY-035; the trial was completed, including both psoriasis patients…
-
CLINICAL_TRIALS trial_result · 2018-01-29Clinical Trial Update: Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis [Phase 2]
Phase 2 trial update for dose-ranging study of R115966 in plaque psoriasis with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2018-01-03Clinical Trial Update: Enstilar in Combination With Biologic Agents [Phase 4]
Phase 4 trial update evaluating Enstilar in combination with biologic agents for psoriasis has been completed.
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: A Study of SHR-1314 in Healthy Subjects [Phase 1]
Phase 1 study of SHR-1314 in healthy subjects has completed; psoriasis is listed as the condition associated with the trial.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 dose-finding study of GSK2894512 cream for plaque psoriasis completed. Results were posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10 [Phase 2]
This report updates the completion of a Phase 2 study evaluating cellular and immunologic changes in the skin of psoriasis patients treated …
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Chronic Plaque Psoriasis Study With Topical Formulation Of GW786034 [Phase 1]
Phase 1 study of a topical GW786034 for chronic plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study [Phase 1]
Phase 1 study of BAY1003803 in psoriasis was terminated. The trial evaluated single- and multiple-dose escalation, safety, tolerability, and…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment [Phase 3]
Phase 3 clinical trial update on guselkumab for moderate to severe plaque-type psoriasis with randomized withdrawal and retreatment.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis [Phase 1]
This clinical trial update describes a Phase 1 study of ABBV-553 assessing pharmacokinetics, safety and tolerability in healthy volunteers a…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or Lupus
A clinical trial update examining patient-centered care and health-related quality of life in people with psoriasis, urticaria, or systemic …
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis. [Phase 3]
A Phase 3 trial comparing Secukinumab to Fumaderm in adults with moderate-to-severe psoriasis has completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis [Phase 3]
Phase 3 clinical trial update for guselkumab in moderate to severe plaque-type psoriasis completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial evaluating apremilast for active psoriatic arthritis using clinical assessments and a joint-periarticular-nail ultras…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis [Phase 2]
This update reports results from a Phase 2 study evaluating the activity, safety, and tolerability of SRT2104 in adults with moderate to sev…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
Completed clinical trial evaluating the comparative effectiveness of psoriasis treatments on systemic inflammation. The summary does not inc…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: The NOR-SWITCH Study [Phase 4]
Phase 4 clinical trial update for NOR-SWITCH study; completed with multiple inflammatory diseases assessed.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease [Phase 4]
Phase 4 trial update evaluating the efficacy of combining fractional CO2 laser with topical tazarotene for nail psoriasis.
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Assessment of Dermatologic Family Impact Scale in the Parents of Children With Psoriasis
A completed clinical trial evaluating the Dermatologic Family Impact Scale in the parents of children with psoriasis to assess its reliabili…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test [Phase 1, Phase 2]
A Phase 1/2 trial evaluating topical C-82 for psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
This document notes the completion of a clinical trial evaluating the cost-effectiveness of systemic treatments for moderate-to-severe psori…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis [Phase 2]
Phase 2 dose-ranging study evaluating the safety and efficacy of the investigational compound GSK2586184 in patients with chronic plaque pso…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis [Phase 1]
This clinical trial update notes the completion of a Phase 1 safety study of BMS-986202 in healthy subjects and its evaluation for psoriasis…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: A Study in Participants With Moderate to Severe Psoriasis [Phase 2]
Phase 2 study in participants with moderate to severe psoriasis completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis [Phase 2]
Phase 2b study of baricitinib in moderate to severe psoriasis completed, with results posted in 2017.